Diagnosis and Management of Cyclic Vomiting Syndrome in Children
Diagnose CVS clinically using Rome IV criteria when children present with stereotypical episodes of acute vomiting lasting less than 7 days, occurring at least 3 times per year (with 2 in the past 6 months), separated by at least 1 week of baseline health, and immediately initiate prophylactic therapy with cyproheptadine for children ≤5 years or amitriptyline for those >5 years if they have moderate-severe disease. 1
Diagnostic Approach
Clinical Criteria
The diagnosis is clinical, based on pattern recognition 2, 1:
Rome IV Criteria:
- Stereotypical episodes of acute-onset vomiting lasting <7 days
- ≥3 discrete episodes per year, with 2 occurring in prior 6 months
- Episodes separated by ≥1 week of baseline health
- Absence of vomiting between episodes (though mild nausea, occasional vomiting, or dyspepsia may persist)
Supportive features that strengthen the diagnosis 2:
- Personal or family history of migraine (present in 52% of pediatric cases) 3
- Prodromal symptoms (65% of patients): sense of impending doom, panic, inability to communicate effectively
- Early morning onset (more common in older children)
- Stereotypical associated symptoms: abdominal pain (present in most), anxiety, headache, diaphoresis, bowel urgency, mental fog
- Hot water bathing behavior for symptom relief (48% of non-cannabis users)
Disease Severity Classification
Critical distinction for treatment decisions 2:
Mild CVS:
- <4 episodes/year
- Each lasting <2 days
- No ED visits or hospitalizations
- Treatment: Abortive therapy only
Moderate-Severe CVS:
- ≥4 episodes/year
- Each lasting >2 days
- Requiring ≥1 ED visit or hospitalization
- Treatment: Both prophylactic AND abortive therapy
Targeted Diagnostic Testing
Avoid "shotgun" testing 1. Use targeted evaluation based on 4 red flags:
- Abdominal signs (bilious vomiting, tenderness)
- Triggering events (fasting, high-protein meals)
- Abnormal neurological exam (altered mental status, papilledema)
- Progressive worsening or changing pattern
If red flags present, investigate for:
Common triggers to identify (80% of differential) 4:
- Psychological stress (26.2%)
- Infections (22%)
- Motion sickness (19.3%)
- Migraine (12.9%)
Diagnostic Pitfalls
Common misdiagnosis issues 3, 5:
- Median diagnostic delay: 1.2 years
- 43.6% initially misdiagnosed elsewhere
- Younger children (≤5 years) have longer diagnostic delays and fewer early morning episodes
- Abdominal pain presence should NOT exclude CVS diagnosis 2
- Hot water bathing is NOT pathognomonic for cannabinoid hyperemesis syndrome 2
Management Strategy
Phase-Based Treatment Approach
CVS has 4 distinct phases requiring different interventions 2:
- Inter-episodic phase: Prophylaxis, trigger management
- Prodromal phase: Abortive therapy (IDEAL timing)
- Emetic phase: Supportive care, symptom control
- Recovery phase: Rehydration, return to baseline
Prophylactic Therapy (Moderate-Severe CVS)
Children ≤5 years:
- Cyproheptadine (first choice)
Children >5 years:
- Amitriptyline (tricyclic antidepressant)
- Starting dose: 25 mg at bedtime
- Goal dose: 75-150 mg or 1-1.5 mg/kg at bedtime
- Titrate slowly: 10-25 mg increments every 2 weeks
- Common side effects: somnolence, dry mouth, blurred vision, constipation, weight gain, prolonged QTc
- Dose at night for better tolerability
Alternative:
- Nortriptyline (may have fewer anticholinergic effects than amitriptyline)
Clinical outcomes 3:
- At 8-year follow-up: 50.7% complete response, 35.3% significant response
- 36.1% of complete responders successfully stopped prophylaxis
- 3 patients relapsed post-withdrawal
Abortive Therapy (All CVS Patients)
Timing is critical: Earlier intervention during prodromal phase = higher success rate 2
Patient education essential: "Rehearse" recognition of prodromal symptoms and immediate action plan 2
Recommended abortive agents 1:
- Triptans (5-HT receptor agonists) during prodromal phase
- Immediate intervention at first prodromal symptom
Acute Episode Management (Emetic Phase)
For patients requiring IV hydration 1:
- 10% dextrose IV fluids
- Ondansetron for nausea/vomiting control
Important considerations 2:
- Patients often cannot communicate effectively during emetic phase
- Rely on caregivers or pre-established treatment plans
- ED providers should have individualized CVS action plan on file 6
- Do NOT misconstrue self-induced vomiting or excessive water drinking as malingering—these are CVS-specific self-soothing behaviors 2
Non-Pharmacologic Management
Trigger identification and mitigation 2:
- Stress management (70-80% have stress triggers)
- Avoid sleep deprivation
- Manage motion sickness
- Address physiological stressors (infections, surgery)
- Avoid prolonged fasting or intense exercise
- Reassurance and anticipatory guidance
- Regular sleep schedule
- Stress reduction techniques
Comorbidity Management
Screen for and treat associated conditions 2:
- Mood disorders (anxiety, depression, panic): present in 50-60% of adults, likely similar in children
- Migraine headaches (20-30%)
- Autonomic dysfunction (postural orthostatic tachycardia syndrome)
Treating comorbidities improves CVS outcomes: anxiety management decreases episode frequency 2
Refractory Cases
If standard therapy fails 5:
- Reconsider underlying organic disease
- Consider combination therapy
- Add psychotherapy/brain-gut behavioral interventions 7
- Evaluate for coalescent CVS (daily symptoms with intermittent severe episodes)
Special Considerations for Younger Children
Children ≤5 years 3:
- Longer diagnostic delays
- More frequent hospitalizations
- Fewer early morning episodes
- Require cyproheptadine as first-line prophylaxis
Key Clinical Pearls
- All patients with moderate-severe CVS require prophylaxis, not just abortive therapy 2
- Abortive therapy works best during prodromal phase—educate families to recognize early warning signs 2
- Abdominal pain is typical, not exclusionary 2
- Hot water bathing is common in CVS, not just cannabinoid hyperemesis 2
- Family history of migraine supports diagnosis 2
- Younger children present differently—maintain high index of suspicion 3
- Develop individualized action plans for ED management 6